Welcome to ORBIS Project website!
The ORBIS Project is a response to the current scientific, economic and social challenge of increasing the effectiveness and productivity of drug development process, both for innovative and (super)generic drugs. This goal can be achieved by interdisciplinary cooperation between the academics from different fields of pharmaceutical sciences and the employees of R&D sector in commercial enterprises. The core of ORBIS is constituted by international, intersectoral exchange of researchers between academic centres and pharmaceutical companies – the consortium partners.
During the secondments planned in the project, young and experienced scientists will cooperate with the hosting institutions on the most relevant and up-to-date issues of drug development process, such as: synthesis and optimisation of new active ingredients, preformulation studies, development of novel oral, dermal and transdermal dosage forms, as well as their biopharmaceutical evaluation with new analytical methods.
About Marie Sklodowska-Curie Research and Innovation Staff Exchange (RISE) programme: